Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

107.40
Delayed Data
As of Sep 13
 -0.86 / -0.79%
Today’s Change
92.56
Today|||52-Week Range
141.86
+10.31%
Year-to-Date

Today’s Trading

Previous close108.26
Today’s open109.33
Day’s range107.23 - 109.74
Volume1,891,446
Average volume (3 months)2,050,417
Market cap$24.1B
Data as of 4:00pm ET, 09/13/2019

Growth & Valuation

Earnings growth (last year)-82.40%
Earnings growth (this year)+25.38%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)+17.00%
P/E ratio18.1
Price/Sales5.29
Price/Book2.62

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+0.36+0.47%
REGNRegeneron Pharmaceut...-2.56-0.90%
SGENSeattle Genetics Inc-0.25-0.35%
MYLMylan NV-0.55-2.47%
Data as of 4:00pm ET, 09/13/2019

Financials

Next reporting dateOctober 28, 2019
EPS forecast (this quarter)$2.46
Annual revenue (last year)$4.1B
Annual profit (last year)$77.6M
Net profit margin1.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Boston, Massachusetts

Forecasts